SUNIL AGARWAL
CIK 1616640 · EVP, Head of Development & CMO · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.61M
Companies
7
Total Filings
53
Lifetime Open-Market Net
-$4.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 3 | 2026-01-23 |
| ARVN | Director | 30,166 | $7.58 | $228.7K | $0 | 3 | 2025-06-30 |
| CALA | Director | — | $0.00 | — | $0 | 8 | 2022-06-03 |
| SANA | EVP, Head of Development & CMO | 1,551,627 | $2.68 | $4.16M | -$1.56M | 4 | 2022-03-08 |
| MyoKardia, Inc. (MYOK) Delisted | Director | 2,300 | — | — | $0 | 8 | 2020-06-23 |
| Juno Therapeutics, Inc. (JUNO) Delisted | President of R & D | 35,893 | — | — | -$326.1K | 5 | 2018-03-07 |
| RARE | Chief Medical Officer | 9,136 | $24.35 | $222.5K | -$2.39M | 21 | 2016-08-23 |
Recent Filings · Page 4 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-21 | RARE | Mixed | −1,042 | -$56.8K | EDGAR |
| 2016-06-16 | CALA | Grant (A) | — | $0 | EDGAR |
| 2016-06-09 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | RARE | Grant (A) | +4,500 | $0 | EDGAR |
| 2016-05-26 | RARE | Sell (S) | −650 | -$42.9K | EDGAR |
| 2016-05-23 | RARE | Tax (F) | −806 | -$50.6K | EDGAR |
| 2016-04-21 | RARE | Mixed | −1,041 | -$73.2K | EDGAR |
| 2016-03-24 | RARE | Sell (S) | −650 | -$39.9K | EDGAR |
| 2016-03-22 | RARE | Tax (F) | −392 | -$22.1K | EDGAR |
| 2016-03-08 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.